APA
Perazzo H., Munteanu M., Ngo Y., Lebray P., Seurat N., Rutka F., Couteau M., Jacqueminet S., Giral P., Monneret D., Imbert-Bismut F., Ratziu V., Hartemann-Huertier A., Housset C. & Poynard T. (20150501). Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. : Alimentary pharmacology & therapeutics.
Chicago
Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C and Poynard T. 20150501. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. : Alimentary pharmacology & therapeutics.
Harvard
Perazzo H., Munteanu M., Ngo Y., Lebray P., Seurat N., Rutka F., Couteau M., Jacqueminet S., Giral P., Monneret D., Imbert-Bismut F., Ratziu V., Hartemann-Huertier A., Housset C. and Poynard T. (20150501). Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. : Alimentary pharmacology & therapeutics.
MLA
Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C and Poynard T. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. : Alimentary pharmacology & therapeutics. 20150501.